ARHGAP30 overexpression significantly inhibited pancreatic cancer cell proliferation, migration, and invasion and promoted apoptosis, whereas ARHGAP30 knockdown resulted in the opposite effects, likely because of RHOA inactivation and β-catenin pathway inactivation, which modulates the expression of related genes. This evidence concerns the gene RHOA and pancreatic neoplasm.